Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening. The company's product includes OMONTYS, a synthetic, peptide-based erythropoiesis stimulating agent designed to stimulate the production of red blood cells and for the treatment of anemia due to chronic kidney disease in adult patients on dialysis.
|HQ||New York, NY, US||Map|
Revenue (FY, 2013)
Net income (FY, 2013)
EBIT (FY, 2013)
Market capitalization (14-Oct-2021)
Closing stock price (14-Oct-2021)
EBIT margin, %
Depreciation and Amortization
When was Affymax founded?
Affymax was founded in 2001.
How many employees does Affymax have?
Affymax has 7 employees.
What is Affymax revenue?
Latest Affymax annual revenue is $1.4 m.
What is Affymax revenue per employee?
Latest Affymax revenue per employee is $195.6 k.
Who are Affymax competitors?
Competitors of Affymax include Neuraxpharm, Fukangren and Alvogen.
Where is Affymax headquarters?
Affymax headquarters is located at 630 5th Ave #2260, New York.
Where are Affymax offices?
Affymax has an office in New York.
How many offices does Affymax have?
Affymax has 1 office.
Receive alerts for 300+ data fields across thousands of companies